Agenda | Institute for Human Genetics Genotech Symposium

	Time	Who	Title	Talk Title
Registration & Breakfast	8:30-9:00
Welcome & Opening Remarks	9:00-9:10	Nadav Ahituv, PhD	Director, Institute for Human Genetics, University of California San Francisco
	9:10-9:15	Tippi MacKenzie, MD	Director, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco
Keynote Speaker	9:15-10:00	Deepak Srivastava, MD	President, Gladstone Institutes; Professor, University of California San Francisco	Heart Disease: From Genetics to Therapeutics
Break	10:00-10:30
Gene Therapy	10:30-10:50	Steven Froelich, PhD	Director, Research and Development, BioMarin
	10:50-11:10	Jennifer Hamilton, PhD	Co-Founder and Chief Executive Officer, Azalea Therapeutics	In vivo CAR-T cell Engineering via Cell-Selective Delivery and Genomic Locus-Specific Integration
	11:10-11:30	Mary McMahon, PhD	Director of Biology, ReviR Therapeutics
	11:30-11:50	Aaron Tward, MD, PhD	Professor, Otolaryngology, University of California San Francisco; Associate Vice President, Gene Therapy, Eli Lilly
	11:50-12:20	Panel Discussion
Lunch & Career Panel	12:20-1:35	Beniamin Krupkin, PhD	Graduate Student, Bioengineering and Therapeutic Sciences, University of California San Francisco	The career panel during lunch with Peng He, Jennifer Hamilton, Marina Bershteyn, and Kanya Rajangam will take the form of a roundtable discussion. Beniamin Krupkin will lead the discussion with a few questions to get the ball rolling and from there we can take questions from trainees in the audience. This session is a great opportunity to learn more about diverse and impactful career paths in the biotech industry.
Cell Therapy	1:35-1:55	Marina Bershteyn, PhD	Senior Director, Discovery Research Department, Neurona Therapeutics	Human GABAergic interneuron cell therapy for drug-resistant focal epilepsy
	1:55-2:15	Kanya Rajangam, MD, PhD	President, Chief Medical Officer and Head of R&D, Senti Biosciences
	2:15-2:35	Deepak A. Lamba, MBBS, PhD	Distinguished Scientist and Director, Ophthalmology Discovery, Genentech	Retinal Cell Therapies: Successes and Challenges to the clinic
	2:35-2:55	Seyedeh Faranak Fattahi, PhD	Associate Professor, Cellular Molecular Pharmacology, University of California San Francisco
	2:55-3:25	Panel Discussion
Break	3:25-3:55
Genomic Technologies	3:55-4:15	Aaron Wenger, PhD	Senior Director, Product Management, PacBio
	4:15-4:35	Siyuan Chen, PhD	Chief Technology Officer, Twist Bioscience
	4:35-4:55	Elena Cassidy, PhD	Chief Executive Officer and Founder, Omabit
	4:55-5:15	Peng He, PhD	Assistant Professor, Pathology, University of California San Francisco
	5:15-5:45	Panel Discussion
Reception	5:45-6:30